The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Momenta Pharmaceuticals competitive analysis

Loading summary...

Latest patents of Momenta Pharmaceuticals opposed by its competitors

Explore Momenta Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP2968549
Nov 23, 2022Methods Of Cell Culture2
EP2971040
Sep 19, 2018Methods Of Cell Culture10

Latest PTAB cases involving Momenta Pharmaceuticals

Discover the latest PTAB cases involving Momenta Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Last updated on: Nov 15, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Momenta Pharmaceuticals

IPR2015-01537Jul 2, 2015MOMENTA PHARMACEUTICALSBRISTOL MYERS SQUIBBFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Momenta Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
MOMENTA PHARMACEUTICALS - 121 -
BAYER3156 - -
DORRIES9 - - -
REGENERON PHARMACEUTICALS3894931